Zeria Pharmaceutical Co., Ltd. · TSE:4559

Zeria Pharmaceutical — Investor Presentation (March 2016)

33 slides from Zeria Pharmaceutical's investor presentation, March 2016

  1. Slide 1: ZERIA Pharmaceutical Co., Ltd.

    ZERIA Pharmaceutical Co., Ltd.

  2. Slide 2: ZERIA Pharmaceutical Co., Ltd.

    ZERIA Pharmaceutical Co., Ltd. 2

  3. Slide 3: ZERIA Pharmaceutical Co., Ltd.

    ZERIA Pharmaceutical Co., Ltd.

  4. Slide 4: u ZERIA Pharmaceutical Co., Ltd.

    u 2014 2015 61,012 100.0% 62,475 100.0% 2.4% 42,539 69.7% 44,548 71.3% 4.7% 39,861 65.3% 39,982 64.0% 0.3% 9,882 16.2% 8,579 13.7% 13.2% 3,102 5.1% 3,256 5.2% 4.9% 2,678 4.4% 4,565 7.3% 70.4% 2,770 4.5% 4,450 7.1% 60.7% 2,557 4.2% 3,513 5.6% 37.4% ZERIA Pharmaceutical Co., Ltd. 4

  5. Slide 5: u ZERIA Pharmaceutical Co., Ltd.

    u 800 620 610 625 600 254 271 287 400 200 364 338 336 0 2013 2014 2015 ZERIA Pharmaceutical Co., Ltd. 5

  6. Slide 6: u u ZERIA Pharmaceutical Co., Ltd.

    u u 2014 2015 33,759 33,580 0.5% 18,264 18,257 0.0% 3,954 3,434 13.1% 3,514 2,965 15.6% 8,923 8,026 11.2% (1,896) ZERIA Pharmaceutical Co., Ltd. 6

  7. Slide 7: u u ZERIA Pharmaceutical Co., Ltd.

    u u (%) 200 120 115 150 110 100 105 100 50 95 0 90 2014 2015 2014 2015 ZERIA Pharmaceutical Co., Ltd. 7

  8. Slide 8: u u ZERIA Pharmaceutical Co., Ltd.

    u u 1.25 1.20 1.15 1.10 1.05 1.00 0.95 2015/1/15 0.90 ZERIA Pharmaceutical Co., Ltd. 8

  9. Slide 9: u ZERIA Pharmaceutical Co., Ltd.

    u 2014 2015 27,095 28,741 6.1% 9,351 10,520 12.5% 4,983 5,894 18.3% 4,368 4,626 5.9% 7,429 7,415 0.2% 1,541 1,601 3.9% 8,772 9,204 4.9% ZERIA Pharmaceutical Co., Ltd. 9

  10. Slide 10: u W W

    u W 50% W 40% 30% 20% 10% 0% 2013 2014 2015 SRI 20134 20163 ZERIA Pharmaceutical Co., Ltd. 10

  11. Slide 11: ZERIA Pharmaceutical Co., Ltd.

    150 5% +5% 27 46 100 58 50 99 86 75 0 2013 2014 2015 ZERIA Pharmaceutical Co., Ltd. 11

  12. Slide 12: u ZERIA Pharmaceutical Co., Ltd.

    u 150 25% 125 120 20% 105 20.0% 90 83 17.2% 15% 13.4% 60 10% 30 5% 0 0% 2013 2014 2015 ZERIA Pharmaceutical Co., Ltd. 12

  13. Slide 13: ZERIA Pharmaceutical Co., Ltd.

    ZERIA Pharmaceutical Co., Ltd.

  14. Slide 14: u l l

    u l l l l l Entocort Asacol l l F.T.Pharma ZERIA Pharmaceutical Co., Ltd. 14

  15. Slide 15: u l l

    u l ‒ l ‒ l ‒ ZERIA Pharmaceutical Co., Ltd. 15

  16. Slide 16: u l l

    u 200,000 50 47 5 1 40 35 150,000 30 25 20 100,000 10 0 50,000 l 0 l l / ZERIA Pharmaceutical Co., Ltd. 16

  17. Slide 17: u l l

    u l l l 120% 110% 100% 0.0–1.85 GASTROENTEROLOGY 1.86–3.09 2012;142:46–54 3.10–4.97 90% 4.98–7.71 2015 2016 7.72–19.2 ZERIA Pharmaceutical Co., Ltd. 17

  18. Slide 18: u Hongo M, J Gastroenterol Hepatol. 2012

    u 800,000 700,000 600,000 500,000 400,000 2008 2009 2010 2011 2012 2013 2014 Hongo M, J Gastroenterol Hepatol. 2012 ZERIA Pharmaceutical Co., Ltd. 18

  19. Slide 19: ZERIA Pharmaceutical Co., Ltd. GASTROENTEROLOGY

    1960-1979 50,000 5 2,000 / 40,885 40,000 30,000 1980-2008 20,000 10,000 0 0.0–0.80 / 0.81–1.94 1.95–3.76 3.77–6.38 GASTROENTEROLOGY 6.39–29.3 2012;142:46–54 ZERIA Pharmaceutical Co., Ltd. 19

  20. Slide 20: u l l

    u l l ‒ l ‒ l 9 25 6 20165 11 ZERIA Pharmaceutical Co., Ltd. 20

  21. Slide 21: l l l

    l l 59 50 36 l 46 l 36 44 l 2013 2014 2015 2016 ZERIA Pharmaceutical Co., Ltd. 21

  22. Slide 22: u l l

    u l l l l ZERIA Pharmaceutical Co., Ltd. 22

  23. Slide 23: u ZERIA Pharmaceutical Co., Ltd.

    u ü ü 80 60 40 66 58 20 33 38 31 0 2014 2015 2016 ZERIA Pharmaceutical Co., Ltd. 23

  24. Slide 24: u ZERIA Pharmaceutical Co., Ltd.

    u ü ü ü ZERIA Pharmaceutical Co., Ltd. 24

  25. Slide 25: u ZERIA Pharmaceutical Co., Ltd.

    u ü ü ü ü 200 180 160 140 120 100 ZERIA Pharmaceutical Co., Ltd. 25

  26. Slide 26: u u Le Van Truyen.“

    u ü ü u Le Van Truyen.“ 2014 ” GMP Platform, http://www.gmp-platform.com/topics_detail1/id=379 GMP Platform ASEAN - 9(2), 1-6 (2014) ASEAN- ZERIA Pharmaceutical Co., Ltd. 26

  27. Slide 27: u u ZERIA Pharmaceutical Co., Ltd.

    u ü ü u ü ZERIA Pharmaceutical Co., Ltd. 27

  28. Slide 28: l Z-215 [PPI] l Z-360 l Z-338

    l Z-215 [PPI] l Z-360 l Z-338 [] [ ] [FD] [H2 ] l Z-338 [FD] [FD] l Z-206 l [UC] Entocort) [UC] [CD] [] u TP05 [UC] l Z-206 u TP09 [FAP] [UC] [] l Z-100 [] [Ca] [] [NSAID] l Z-213 [] [] FD UC CD FAP NSAID ZERIA Pharmaceutical Co., Ltd. 28

  29. Slide 29: u l l

    u l 100 l 80 60 l 40 l 20 l 0 2015 2016 ZERIA Pharmaceutical Co., Ltd. 29

  30. Slide 30: ZERIA Pharmaceutical Co., Ltd.

    2015 2016 62,475 66,000 5.6% 4,565 4,800 5.1% 4,450 4,600 3.4% 3,513 3,600 2.5% 31 32 ― 8,579 9,500 10.7% 3,256 3,800 22.5% 12,516 16,949 35.4% ZERIA Pharmaceutical Co., Ltd. 30

  31. Slide 31: ZERIA Pharmaceutical Co., Ltd.

    800 660 610 625 600 287 303 271 400 200 338 336 355 0 2014 2015 2016 ZERIA Pharmaceutical Co., Ltd. 31

  32. Slide 32: ZERIA Pharmaceutical Co., Ltd.

    150 48 27 46 100 58 50 99 95 86 75 0 2013 2014 2015 2016 ZERIA Pharmaceutical Co., Ltd. 32

  33. Slide 33: ZERIA Pharmaceutical Co., Ltd.

    ZERIA Pharmaceutical Co., Ltd. 33

ZERIA Pharmaceutical — Investor Presentation (March 2016) on 6ix